Gilead Sciences signed licensing agreements with six generic manufacturers to increase access to lenacapavir for HIV prevention. But no, it will still not be...
A study suggests that initiating antiretroviral therapy (ART) on the same day as HIV testing may actually lead to improved retention and outcomes in...
A study finds increasing HIV resistance against antiretroviral (ARV) drug tenofovir – an alarming development since tenofovir was initially thought to be less prone...